Adaptive Biotechnologies(ADPT) - 2025 Q2 - Quarterly Results

Adaptive Biotechnologies Reports Second Quarter 2025 Financial Results EXHIBIT 99.1 SEATTLE, Aug. 05, 2025 (GLOBE NEWSWIRE) – Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended June 30, 2025. "We delivered an outstanding second quarter, achieving profitability in o ...